Clinical Trials Directory

Trials / Unknown

UnknownNCT03173287

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
63 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Quantification of hepatic fibrosis by IVIM sequences in 1.5T MRI.

Detailed description

Early and accurate diagnosis of hepatic fibrosis in patients with chronic liver disease is essential and essential. This assessment could be performed by a non-invasive MRI method. The main objective of this study is to show that the measured perfusion-related scattering value (D \*) is related to the hepatic fibrosis stage. Secondary objectives * Evaluation of infusion fraction (f) and fibrosis stage. * Evaluation of molecular diffusion (D) and fibrosis stage. * Evaluation of ADC and fibrosis stage. * Assess whether there is a link between the etiology of fibrosis and the value of the diffusion.

Conditions

Interventions

TypeNameDescription
PROCEDUREQuantification of liver fibrosisProcedure MRI and liver biopsy

Timeline

Start date
2017-03-01
Primary completion
2017-03-01
Completion
2018-11-01
First posted
2017-06-01
Last updated
2017-06-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03173287. Inclusion in this directory is not an endorsement.